Question 1

What are the potential side effects of Umbralisib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma clinical trial (NCT03364231). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma clinical trial (NCT03364231). Contact the study team or your healthcare provider for specific answers.

Question 3

What will my treatment schedule look like if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma clinical trial (NCT03364231). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests or monitoring I will need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma clinical trial (NCT03364231). Contact the study team or your healthcare provider for specific answers.

Question 5

How will this trial affect my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma clinical trial (NCT03364231). Contact the study team or your healthcare provider for specific answers.

Question 6

What should I do if I experience side effects while on this medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma clinical trial (NCT03364231). Contact the study team or your healthcare provider for specific answers.

What this study is about